Baxter International Inc. is voluntarily recalling one lot of Anticoagulant Sodium Citrate Solution due to the potential presence of particulate matter identified as fiberglass in the solution.
This solution is intended for use with automated apheresis devices. Administration of Anticoagulant Sodium Citrate containing particulate matter may lead to adverse health consequences, such as local vein irritation, inflammatory or hypersensitivity reactions, and systemic embolization, which could result in tissue or organ injury if in-line filtration is absent.
As of August 25, 2026, Baxter has not received any reports of adverse events related to this issue.